Potency and antimicrobial spectrum update for piperacillin/tazobactam (2000): emphasis on its activity against resistant organism populations and generally untested species causing community-acquired respiratory tract infections
- 31 May 2002
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 43 (1) , 49-60
- https://doi.org/10.1016/s0732-8893(02)00358-9
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- A Multicenter, Double‐Blind, Placebo‐Controlled Trial Comparing Piperacillin‐Tazobactam with and without Amikacin as Empiric Therapy for Febrile NeutropeniaClinical Infectious Diseases, 2001
- Worldwide Prevalence of Antimicrobial Resistance inStreptococcus pneumoniae, Haemophilus influenzae,andMoraxella catarrhalisin the SENTRY Antimicrobial Surveillance Program, 1997–1999Clinical Infectious Diseases, 2001
- In-vitro activity of piperacillin/tazobactam relative to other antibiotics against blood culture isolatesIrish Journal of Medical Science, 1998
- Treatment of Ventilator‐Associated Pneumonia with Piperacillin‐Tazobactam/Amikacin Versus Ceftazidime/Amikacin: A Multicenter, Randomized Controlled TrialClinical Infectious Diseases, 1998
- 1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained FeverClinical Infectious Diseases, 1997
- National survey of the in vitro spectrum of piperacillin-tazobactam tested against more than 40,000 aerobic clinical isolates from 236 medical centersDiagnostic Microbiology and Infectious Disease, 1995
- Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of CancerAntimicrobial Agents and Chemotherapy, 1995
- Comparative activities of piperacillin and tazobactam against clinical isolates of Legionella sppAntimicrobial Agents and Chemotherapy, 1994
- A randomized multicenter trial of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of severe intra-abdominal infectionsJournal of Antimicrobial Chemotherapy, 1993
- Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infectionsAntimicrobial Agents and Chemotherapy, 1992